litlas
ログインアカウント作成

Donald P. Tashkin

1973–2025 年に発表

216
論文数
32,431
被引用数
110
h 指数
208
i10 指数

被引用数

Donald P. Tashkin の年別被引用数1974 年: 被引用 1 件1976 年: 被引用 4 件1978 年: 被引用 5 件1979 年: 被引用 3 件1980 年: 被引用 6 件1982 年: 被引用 3 件1983 年: 被引用 3 件1984 年: 被引用 9 件1985 年: 被引用 11 件1986 年: 被引用 6 件1987 年: 被引用 20 件1988 年: 被引用 10 件1989 年: 被引用 16 件1990 年: 被引用 15 件1991 年: 被引用 24 件1992 年: 被引用 15 件1993 年: 被引用 35 件1994 年: 被引用 36 件1995 年: 被引用 32 件1996 年: 被引用 49 件1997 年: 被引用 57 件1998 年: 被引用 66 件1999 年: 被引用 83 件2000 年: 被引用 89 件2001 年: 被引用 107 件2002 年: 被引用 131 件2003 年: 被引用 148 件2004 年: 被引用 139 件2005 年: 被引用 168 件2006 年: 被引用 186 件2007 年: 被引用 190 件2008 年: 被引用 191 件2009 年: 被引用 215 件2010 年: 被引用 215 件2011 年: 被引用 280 件2012 年: 被引用 249 件2013 年: 被引用 272 件2014 年: 被引用 295 件2015 年: 被引用 236 件2016 年: 被引用 246 件2017 年: 被引用 199 件2018 年: 被引用 283 件2019 年: 被引用 902 件2020 年: 被引用 869 件2021 年: 被引用 829 件2022 年: 被引用 604 件2023 年: 被引用 456 件2024 年: 被引用 618 件2025 年: 被引用 271 件2026 年: 被引用 4 件1975 年は被引用が無いため表示していません1977 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,858 件、この内訳の 27.1%イギリス: 引用元論文 1,081 件、この内訳の 10.3%カナダ: 引用元論文 638 件、この内訳の 6%イタリア: 引用元論文 544 件、この内訳の 5.2%ドイツ: 引用元論文 481 件、この内訳の 4.6%中国: 引用元論文 448 件、この内訳の 4.2%フランス: 引用元論文 401 件、この内訳の 3.8%スペイン: 引用元論文 371 件、この内訳の 3.5%オーストラリア: 引用元論文 365 件、この内訳の 3.5%オランダ: 引用元論文 356 件、この内訳の 3.4%日本: 引用元論文 239 件、この内訳の 2.3%スイス: 引用元論文 230 件、この内訳の 2.2%
0%27.1%その他 23.9%

機関

分野

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Environmental Science1.5%
  • Immunology and Microbiology1.5%
  • Neuroscience1.1%
  • Health Professions0.7%
  • その他3.2%

トピック

  • Chronic Obstructive Pulmonary Disease (COPD) Research12%
  • Asthma and respiratory diseases7%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis5.5%
  • Systemic Sclerosis and Related Diseases5.2%
  • Cannabis and Cannabinoid Research3.9%
  • Respiratory Support and Mechanisms3.9%
  • その他62.5%

共著者

全論文

検索で開く
  1. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    著者: Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Dinesh Khanna, Eric C. Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R. Volkmann, Suzanne Kafaja, Richard M. Silver, Virginia Steen, Charlie Strange, Robert A. Wise, Fredrick M. Wigley, Maureen D. Mayes, D. Jason Riley, Sabiha Hussain, Shervin Assassi, Vivien Hsu, Bela Patel, Kristine Phillips, Fernando J. Martínez, Jeffrey A. Golden, M. Kari Connolly, John Varga, Jane Dematte, Monique Hinchcliff, Aryeh Fischer, Jeffrey J. Swigris, Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 被引用: 1,062

  2. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

    著者: Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Jonathan Goldin, Michael D. Roth, Daniel E. Furst, Edgar Arriola, Richard M. Silver, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fredrick M. Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky - New England Journal of Medicine 2006 被引用: 1,667

  3. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    著者: Prescott G. Woodruff, R. Graham Barr, Eugene R. Bleecker, Stephanie A. Christenson, David Couper, Jeffrey L. Curtis, Natalia Gouskova, Nadia N. Hansel, Eric A. Hoffman, Richard E. Kanner, Eric C. Kleerup, Stephen C. Lazarus, Fernando J. Martínez, Robert Paine, Stephen I. Rennard, Donald P. Tashkin, MeiLan K. Han - New England Journal of Medicine 2016 被引用: 690

  4. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

    著者: MeiLan K. Han, P. Miguel Quibrera, Elizabeth E. Carretta, R. Graham Barr, Eugene R. Bleecker, Russell P. Bowler, Christopher B. Cooper, Alejandro P. Comellas, David Couper, Jeffrey L. Curtis, Gerard J. Criner, Mark T. Dransfield, Nadia N. Hansel, Eric A. Hoffman, Richard E. Kanner, Jerry A. Krishnan, Carlos H Martinez, Cheryl Pirozzi, Wanda K. O’Neal, Stephen I. Rennard, Donald P. Tashkin, Jadwiga A. Wedzicha, Prescott G. Woodruff, Robert Paine, Fernando J. Martínez, Neil E. Alexis, Wayne H. Anderson, R. Graham Barr, Eugene R. Bleecker, Richard C. Boucher, Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 被引用: 318

  5. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

    著者: Donald P. Tashkin, Bartolomé R. Celli, Stephen Senn, D Burkhart, Steven Kesten, Shailendra Menjoge, Marc Decramer - New England Journal of Medicine 2008 被引用: 2,199

  6. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease

    著者: Dinesh Khanna, Donald P. Tashkin, Christopher P. Denton, Elisabetta Renzoni, Sujal R. Desai, John Varga - American Journal of Respiratory and Critical Care Medicine 2019 被引用: 193

  7. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort

    著者: Annette T. Hastie, Fernando J. Martínez, Jeffrey L. Curtis, Claire M. Doerschuk, Nadia N. Hansel, Stephanie A. Christenson, Nirupama Putcha, Victor E. Ortega, Xingnan Li, R. Graham Barr, Elizabeth E. Carretta, David Couper, Christopher B. Cooper, Eric A. Hoffman, Richard E. Kanner, Eric C. Kleerup, Wanda K. O’Neal, Richard R. Paine, Stephen P. Peters, Neil E. Alexis, Prescott G. Woodruff, MeiLan K. Han, Deborah A. Meyers, Eugene R. Bleecker, Neil E. Alexis, Wayne H. Anderson, R. Graham Barr, Eugene R. Bleecker, Richard C. Boucher, Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 被引用: 317

  8. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Myung‐Shin Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E. Furst, Philip J. Clements, Dinesh Khanna, Virginia Steen, Dean E. Schraufnagel, Shiva Arami, Vivien Hsu, Michael D. Roth, Robert M. Elashoff, Keith M. Sullivan - Annals of the Rheumatic Diseases 2018 被引用: 198

  9. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease

    著者: Donald P. Tashkin, Michael E. Wechsler - International Journal of COPD 2018 被引用: 173

  10. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Ning Li, Michael D. Roth, Dinesh Khanna, Anna‐Maria Hoffmann‐Vold, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Robert M. Elashoff - Arthritis & Rheumatology 2017 被引用: 159

  11. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study

    著者: Russell G. Buhr, Igor Barjaktarević, P. Miguel Quibrera, Lori A. Bateman, Eugene R. Bleecker, David Couper, Jeffrey L. Curtis, Brett A. Dolezal, MeiLan K. Han, Nadia N. Hansel, Jerry A. Krishnan, Fernando J. Martínez, William McKleroy, Robert Paine, Stephen I. Rennard, Donald P. Tashkin, Prescott G. Woodruff, Richard E. Kanner, Christopher B. Cooper - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 45

  12. Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

    著者: Suzanne Kafaja, Philip J. Clements, Holly Wilhalme, Chi‐Hong Tseng, Daniel E. Furst, Grace Hyun J. Kim, Jonathan Goldin, Elizabeth R. Volkmann, Michael D. Roth, Donald P. Tashkin, Dinesh Khanna - American Journal of Respiratory and Critical Care Medicine 2017 被引用: 126

  13. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II

    著者: Jonathan Goldin, Grace Hyun J. Kim, Chi‐Hong Tseng, Elizabeth R. Volkmann, Daniel E. Fürst, Philip J. Clements, Matthew A. Brown, Michael D. Roth, Dinesh Khanna, Donald P. Tashkin - Annals of the American Thoracic Society 2018 被引用: 112

  14. Gender Bias in the Diagnosis of COPD

    著者: Kenneth R. Chapman, Donald P. Tashkin, David J. Pye - CHEST Journal 2001 被引用: 399

  15. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years

    著者: Surya P. Bhatt, Young‐Il Kim, Kathy Harrington, John E. Hokanson, Sharon M. Lutz, Michael H. Cho, Dawn L. DeMeo, J. Michael Wells, Barry J. Make, Stephen I. Rennard, George R. Washko, Marilyn G. Foreman, Donald P. Tashkin, Robert A. Wise, Mark T. Dransfield, William C. Bailey - Thorax 2018 被引用: 160

  16. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide

    著者: Hyun J. Kim, Matthew S. Brown, Robert M. Elashoff, Gang Li, David W. Gjertson, David A. Lynch, Diane C. Strollo, Eric C. Kleerup, Daniel Chong, Sumit K. Shah, Shama Ahmad, Fereidoun Abtin, Donald P. Tashkin, Jonathan Goldin - European Radiology 2011 被引用: 123

  17. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Dinesh Khanna, Daniel E. Furst, Maureen D. Mayes, Julio Charles, Chi‐Hong Tseng, Robert M. Elashoff, Shervin Assassi - Arthritis Research & Therapy 2016 被引用: 86

  18. Early Radiographic Progression of Scleroderma

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Jonathan Goldin, Grace H.J. Kim - CHEST Journal 2021 被引用: 37

  19. Effects of Marijuana Smoking on the Lung

    著者: Donald P. Tashkin - Annals of the American Thoracic Society 2013 被引用: 292

  20. Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis

    著者: Shervin Assassi, William R. Swindell, Minghua Wu, F. Tan, Dinesh Khanna, Daniel E. Furst, Donald P. Tashkin, Richard R. Jahan‐Tigh, Maureen D. Mayes, Jóhann E. Guðjónsson, Jeffrey T. Chang - Arthritis & Rheumatology 2015 被引用: 153

  21. Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

    著者: David Halpin, Marc Decramer, Bartolomé R. Celli, Steven Kesten, Inge Leimer, Donald P. Tashkin - Lung 2011 被引用: 86

  22. Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT

    著者: Nirupama Putcha, Antonio R. Anzueto, Peter M. A. Calverley, Bartolomé R. Celli, Donald P. Tashkin, Norbert Metzdorf, Achim Mueller, Robert A. Wise - Annals of the American Thoracic Society 2021 被引用: 58

  23. Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

    著者: Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li - American Journal of Respiratory and Critical Care Medicine 2007 被引用: 464

  24. Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

    著者: Li Zhu, Sherven Sharma, Marina Stolina, Brian Gardner, Michael D. Roth, Donald P. Tashkin, Steven M. Dubinett - The Journal of Immunology 2000 被引用: 253